1280P Effects of semaglutide on the exposure of alectinib in patients with NSCLC
Lanser, D.A.C., Heersche, N., Oomen-de Hoop, E., Icli, A., de Bruijn, P., Paats, M.S., van Rossum, E., Koolen, S.L., Van Schaik, R., Dingemans, A-M.C., Veerman, M.G.D., Mathijssen, R.H.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1281P Impact of common germline variants on the toxicity profile and pharmacokinetics of alectinib
Heersche, N., Lanser, D.A.C., Muntinghe, B., Mohmaed Ali, M.I., Ulas, E.B., Trooster, T.M.A., de Jonge, E., Oomen-de Hoop, E., Paats, M.S., Bahce, I., Croes, S., Hendriks, L.E., Van Der Wekken, A.J., Dingemans, A-M.C., Huitema, A.D.R., Van Schaik, R., Mathijssen, R.H., Veerman, M.G.D.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article